investorscraft@gmail.com

Intrinsic ValueEms-Chemie Holding AG (EMSN.SW)

Previous CloseCHF601.00
Intrinsic Value
Upside potential
Previous Close
CHF601.00

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Ems-Chemie Holding AG operates as a global leader in high-performance polymers and specialty chemicals, serving diverse industries such as automotive, electronics, and packaging. The company's core revenue model is built on manufacturing and supplying advanced polyamides granulates, adhesives, and coatings, which are critical for high-demand applications like tire bonding and technical textiles. Its vertically integrated production capabilities and strong R&D focus enable it to deliver tailored solutions, reinforcing its competitive edge in niche markets. Ems-Chemie’s market position is bolstered by its long-standing expertise and proprietary technologies, allowing it to maintain premium pricing and customer loyalty. The company’s dual-segment approach—High Performance Polymers and Specialty Chemicals—ensures diversified revenue streams while addressing evolving industrial needs. With a reputation for innovation and reliability, Ems-Chemie is well-positioned to capitalize on trends like lightweight materials in automotive and sustainable adhesives.

Revenue Profitability And Efficiency

In its latest fiscal year, Ems-Chemie reported revenue of CHF 2.07 billion, with net income of CHF 460.8 million, reflecting a robust net margin of approximately 22.3%. The company’s operating cash flow stood at CHF 480.4 million, underscoring efficient cash generation. Capital expenditures were modest at CHF 32.9 million, indicating disciplined investment in maintaining and upgrading production capabilities.

Earnings Power And Capital Efficiency

Ems-Chemie demonstrates strong earnings power, with diluted EPS of CHF 19.7, supported by high-margin specialty products. The company’s capital efficiency is evident in its low debt levels (CHF 8.8 million) and substantial cash reserves (CHF 518.4 million), enabling flexibility for strategic investments or shareholder returns without compromising financial stability.

Balance Sheet And Financial Health

The balance sheet is exceptionally healthy, with cash and equivalents exceeding total debt by a wide margin. This conservative leverage profile, combined with consistent cash flow generation, positions Ems-Chemie to weather economic downturns and pursue growth opportunities without undue financial risk.

Growth Trends And Dividend Policy

Ems-Chemie has maintained a steady dividend policy, with a dividend per share of CHF 13.95, reflecting its commitment to returning capital to shareholders. Growth trends are supported by demand for high-performance materials in automotive and industrial applications, though the company’s niche focus may limit exposure to broader market fluctuations.

Valuation And Market Expectations

With a market capitalization of CHF 14.45 billion and a beta of 0.75, Ems-Chemie is perceived as a stable, low-volatility investment. The valuation reflects its premium positioning in specialty chemicals, though investors may weigh its growth prospects against its already high profitability margins.

Strategic Advantages And Outlook

Ems-Chemie’s strategic advantages lie in its technological expertise, vertical integration, and strong customer relationships. The outlook remains positive, driven by secular trends in lightweight materials and sustainable industrial solutions, though the company’s growth may be tempered by its selective market focus and reliance on high-end applications.

Sources

Company filings, Bloomberg

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount